Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

TBX4 enhancer based precision gene targeting for lung health

Objective

Chronic respiratory diseases (CRDs) represent a major global health burden, with limited therapeutic options available. Gene therapy offers significant potential; however, current approaches often lack organ specificity, resulting in off-target effects. TBX4-PRECIS is a novel lung-specific gene delivery platform based on a uniquely engineered genetic sequence that enables precise targeting of therapeutic genes to the lung. Unlike conventional promoter-based systems, TBX4-PRECIS provides highly specific, carrier-agnostic expression of transgenes or antisense molecules in lung tissue, thereby improving targeting precision and minimizing off-target activity.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2026-POC

See all projects funded under this call

Host institution

JUSTUS-LIEBIG-UNIVERSITAET GIESSEN
Net EU contribution
€ 150 000,00
Address
LUDWIGSTRASSE 23
35390 GIESSEN
Germany
Region
Berlin Berlin Berlin
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)